PCM
AVEO

Pentwater Capital Management’s AVEO Pharmaceuticals, Inc. AVEO Stock Holding History

Pentwater Capital Management’s Portfolio AVEO Stock Details AVEO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-551,478
Closed -$8.24M – 188
2022
Q4 		$8.24M Buy
+551,478
New +$7.64M 0.14% 58

Pentwater Capital Management's AVEO Position: Q1 2023 in Review

Pentwater Capital Management sold out of AVEO Pharmaceuticals, Inc. (AVEO) in Q1 2023, closing a stake of 551,478 shares — an estimated $8.24M sold.

Pentwater Capital Management first reported a position in AVEO in Q4 2022 and held it in 1 quarter. The position peaked at $8.24M in Q4 2022. 0 funds tracked by Wall St. Rank hold AVEO as of Q1 2023.

  • Pentwater Capital Management reported no remaining AVEO Pharmaceuticals, Inc. position as of Q1 2023 after selling out during the quarter.
  • Pentwater Capital Management sold 551,478 AVEO Pharmaceuticals, Inc. shares in Q1 2023, an estimated $8.24M.
  • Pentwater Capital Management first reported a position in AVEO Pharmaceuticals, Inc. in Q4 2022 and held it in 1 quarter.
  • Pentwater Capital Management's AVEO Pharmaceuticals, Inc. position peaked at $8.24M in Q4 2022.
  • 0 funds tracked by Wall St. Rank held AVEO Pharmaceuticals, Inc. as of Q1 2023.

Based on Pentwater Capital Management's 13F filing for Q1 2023, filed 15 May 2023.